Mealey's PI/Product Liability - Purdue Pharma Claims $10B Opioid Settlement, Files For Chapter 11 Bankruptcy

NEW YORK - OxyContin maker Purdue Pharma L.P. on Sept. 15 announced that it has reached an agreement in principle to settle its opioid litigation for more than $10 billion and filed for reorganization under Chapter 11 of the U.S. Bankruptcy Code (In Re: Purdue Pharma L.P., et al., No. 19-23649, U.S. Bkcy. S.D. N.Y.).
Find full version on lexis Advance®